The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Postdoctoral Research Associate, Molecular Pharmacology Lab of Dr. Steven M. Larson, Department of Radiology and Sloan Kettering Institute
The Larson lab is seeking a highly motivated and successful individual with a background in radiochemistry, imaging science, chemical biology, or chemistry to undertake preclinical radiotheranostic development for the systemic treatment of solid tumors with alpha- or beta-emitting unsealed isotopes, guided by PET-based staging and dosimetry. We collaborate closely with the lab of Dr. Nai-kong Cheung to employ bispecific antibodies for anti-tumor/anti-radiohapten in vivo pretargeting. Please see https://www.mskcc.org/research/ski/labs/steven-larson for additional information. This full-time post is funded by the National Institutes of Health, National Cancer Institute.
T he ideal candidate should have:
A Ph.D or M.D., or be near completion of their degree, in a relevant subject area.
Background in radiochemistry, organic chemistry, imaging science, autoradiography/immunohistochemistry, or chemical biology. No previous experience in molecular imaging required.
The desire to be a part of a dynamic translational research team.
Please upload CV, a letter outlining your interest and names/contact information of three references with your application. Please direct any questions to Sarah M. Cheal, PhD, Senior Research Scientist, Larson Lab - Cheals@mskcc.org.
#LI-POST
Internal Number: 2020-44741
About Memorial Sloan Kettering Cancer Center
At Memorial Sloan Kettering (MSK), we’re not only changing the way we treat cancer, but also the way the world thinks about it. By working together and pushing forward with innovation and discovery, we’re driving excellence and improving outcomes.
For the 28th year, MSK has been named a top hospital for cancer by U.S. News & World Report. We are proud to be on Becker’s Healthcare list as one of the 150 Great Places to Work in Healthcare in 2018, as well as one of Glassdoor’s Employees’ Choice Best Place to Work for 2018. We’re treating cancer, one patient at a time. Join us and make a difference every day.
